MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma?
- PMID: 19636633
- DOI: 10.1245/s10434-009-0623-1
MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma?
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is known for its very poor overall prognosis, making tools for early diagnosis and new therapeutic modalities urgently needed. MicroRNAs (miRNAs), endogenous noncoding RNA molecules of approximately 22 nt, have gained attention as an epigenetic component involved in the development of many cancers, including PDAC. miRNA expression profiles of varying pancreatic tissues have identified a number of differentially expressed miRNAs and seem to be able to differentiate between three tissues of clinical importance: normal pancreas, chronic pancreatitis, and PDAC. This article gathers our current knowledge of differentially expressed miRNAs in pancreatic tissues with relevance to PDAC and presents potential diagnostic and therapeutic opportunities.
Similar articles
-
MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma.Oncogene. 2007 Jun 28;26(30):4442-52. doi: 10.1038/sj.onc.1210228. Epub 2007 Jan 22. Oncogene. 2007. PMID: 17237814
-
Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.Ann Surg Oncol. 2009 Aug;16(8):2339-50. doi: 10.1245/s10434-009-0531-4. Epub 2009 May 28. Ann Surg Oncol. 2009. PMID: 19475450
-
Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.Int J Cancer. 2012 Jul 15;131(2):E86-95. doi: 10.1002/ijc.26466. Epub 2011 Nov 19. Int J Cancer. 2012. PMID: 21953293
-
Clinical potential of microRNAs in pancreatic ductal adenocarcinoma.Pancreas. 2011 Nov;40(8):1165-71. doi: 10.1097/MPA.0b013e3182218ffb. Pancreas. 2011. PMID: 22001830 Review.
-
Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment.Pancreas. 2011 Jul;40(5):644-52. doi: 10.1097/MPA.0b013e31821ff741. Pancreas. 2011. PMID: 21673535 Review.
Cited by
-
Elevated expression of mature miR-21 and miR-155 in cancerous gastric tissues from Chinese patients with gastric cancer.J Biomed Res. 2010 May;24(3):187-97. doi: 10.1016/S1674-8301(10)60028-0. J Biomed Res. 2010. PMID: 23554630 Free PMC article.
-
Molecular characterization of patient-derived human pancreatic tumor xenograft models for preclinical and translational development of cancer therapeutics.Neoplasia. 2013 Oct;15(10):1138-50. doi: 10.1593/neo.13922. Neoplasia. 2013. PMID: 24204193 Free PMC article.
-
Small nucleolar RNA U91 is a new internal control for accurate microRNAs quantification in pancreatic cancer.BMC Cancer. 2015 Oct 24;15:774. doi: 10.1186/s12885-015-1785-9. BMC Cancer. 2015. PMID: 26499892 Free PMC article.
-
Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer.PLoS One. 2010 May 14;5(5):e10630. doi: 10.1371/journal.pone.0010630. PLoS One. 2010. PMID: 20498843 Free PMC article.
-
Circulating microRNAs as Potential Biomarkers in Pancreatic Cancer-Advances and Challenges.Int J Mol Sci. 2023 Aug 28;24(17):13340. doi: 10.3390/ijms241713340. Int J Mol Sci. 2023. PMID: 37686149 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
